Arsenal Medical has announced that NeoCast—a first-of-its-kind liquid embolic designed for deep distal penetration—met its primary feasibility and safety endpoints in the multicentre, prospective EMBO-01 trial. #snis2024 Society of NeuroInterventional Surgery Lee-Anne Slater David Fiorella Upma Sharma, PhD
NeuroNews
Medical Equipment Manufacturing
International neurointervention newspaper. Follow for breaking news, exclusive interviews, conference coverage and more.
About us
NeuroNews is a medical publication providing the latest news from the neurovascular and neuromodulation fields. Our target audience consists of neurointerventionists and interventional neuroradiologists, as well as neurosurgeons, neurologists, stroke physicians and pain management specialists. Through our print newspaper, website and social media channels, we deliver breaking news, exclusive interviews, conference coverage and original content on everything from stroke care and intracranial aneurysm treatments, to carotid artery disease and brain stimulation.
- Website
-
https://www.neuronewsinternational.com
External link for NeuroNews
- Industry
- Medical Equipment Manufacturing
- Company size
- 2-10 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2010
- Specialties
- interventional neuroradiology, stroke, intracranial aneurysms, neuromodulation, spinal cord stimulation, deep brain stimulation, neuroradiologists, neurologist, neurovascular, aneurysms, stroke physicians, and pain management specialists
Locations
-
Primary
London, SW6 5NR, GB
Updates
-
MicroVention-Terumo has announced the recent publication in #jnis of one-year results from CLEVER—a study that sought to provide a clinical evaluation with the Woven EndoBridge (WEB) 17 device in treating ruptured and unruptured #aneurysms. #snis2024 Society of NeuroInterventional Surgery Laurent SPELLE Adam Arthur Carsten Schroeder
Microvention announces publication of one-year results from CLEVER study
neuronewsinternational.com
-
Changing standard procedures for evaluating and treating patients with suspected #stroke has led to improved thrombectomy access across the US state of Delaware, and should inform triage + treatment nationwide, per research released at #snis2024. Society of NeuroInterventional Surgery Thinesh Sivapatham
Study indicates updated stroke evaluation protocols increase patient access to thrombectomy treatment
neuronewsinternational.com
-
Rapid Medical has announced the first procedures in the USA with its breakthrough deflectable access platform Drivewire 24, doing so at the ongoing Society of NeuroInterventional Surgery meeting. This milestone follows the recent US FDA clearance of the device. #snis2024 Shahram Majidi Giora Kornblau
Rapid Medical completes initial neurovascular cases in USA with Drivewire 24 following FDA clearance
neuronewsinternational.com
-
Worsening air quality and temperature extremes are linked to increased #stroke burden—a trend found to disproportionately impact underserved US communities—according to a study presented this week at #snis2024. Society of NeuroInterventional Surgery Cleveland Clinic
Stroke risk linked to climate, financial and medical vulnerability in US study
neuronewsinternational.com
-
Q'Apel Medical has announced the appointment of Jodie Fam as its new chief executive officer. Fam succeeds R King Nelson, who retires after leading the company for the past five years and will continue to serve on Q’Apel’s board of directors.
Q’Apel Medical appoints Jodie Fam as new CEO
neuronewsinternational.com
-
Route 92 Medical has announced the commercial launch of the FreeClimb 88 catheter system comprising the FreeClimb 88 catheter and the Tenzing 8 delivery catheter—all designed to work with the Base Camp sheath. Ajit Puri Thanh Nguyen Guilherme Dabus, MD, MHL, FACR, FAHA Tony Chou
Route 92 Medical announces commercial launch of FreeClimb 88 catheter system
neuronewsinternational.com
-
NeuroNews reposted this
Head of Diagnostic and Interventional Neuroradiology, Clinic of Radiology & Nuclear Medicine, University Hospital Basel
We finally reached the summit 🏔️⛏️ in July on a final push 🧗♀️ towards 100% patient recruitment!!! Congratulations 🎉 to the entire team of 61 hospitals ‼️ on this incredible achievement and gratitude 🙏🏼 to all participants! We are so proud and looking forward to the results 🤩 Prof. Dr. Panagiotis Papanagiotou Urs Fischer Mira Katan Juan F. Arenillas Lara Manuel Moreu Gamazo Guillaume Saliou Steven Hajdu Jan Gralla Daniel KAISER Robin Lemmens Flavio Bellante Frans Van den Bergh Aad van der Lugt Wim van Zwam Grzegorz Karwacki Alexander von Hessling Jens Fiehler Gabriel Broocks Lukas Meyer Adriaan C.G.M. van Es Jonathan Coutinho Ido van den Wijngaard Departement Klinische Forschung, Universität Basel University Hospital Basel Medizinische Fakultät | Universität Basel Florian Peters Niklaus Labhardt Andrea Zini Leonardo Renieri Luzia Balmer Paul Bhogal Johan Wassélius Donald Lobsien Carlo W. Cereda Eleftherios Remoundos Dr. med. Thilo Rusche Victor Schulze-Zachau Ioannis Tsogkas Kristine Blackham Theodosios Tsinas #Neuroradiology #neurology #TeamUSB #StrokeCenterBasel #stroke #mevo #dvo
-
-
Saluda Medical has announced the recent presentation of two abstracts analysing biomarker-based spinal cord stimulation data at the 2024 American Society of Pain and Neuroscience ASPN meeting. #neuromodulation #scs #chronicpain Robert Levy Jason E. Pope, MD, DABPM, FIPP Jim Schuermann
Saluda announces presentation of two chronic pain biomarker-based analyses at ASPN 2024
neuronewsinternational.com
-
Anaconda BioMed has received conditional IDE approval from the US FDA to begin the ATHENA study of its ANA funnel catheter, evaluating the safety and effectiveness of mechanical #thrombectomy using the device in combination with a stent retriever. Adnan Siddiqui, MD, PhD Francois Salmon Hendrik Lambert
Anaconda Biomed receives IDE approval to initiate enrolment in ATHENA study
neuronewsinternational.com